The effectiveness of adding famotidine and vitamin B6 to standard drug treatment in patients with schizophrenia disorder
Phase 2
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20150822023705N16
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Schizophrenia Disorder diagnoses with negative symptoms according to Diagnostic and Statistical Manual of Mental Disorders fifth edition by a psychiatrist
under treatment with aripiprazole
Exclusion Criteria
Disagreement to participate in the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of negative symptoms. Timepoint: before intervention- 6 weeks later- 12 weeks late. Method of measurement: Positive and Negative Symptom Scale.
- Secondary Outcome Measures
Name Time Method